Diabetic foot ulcers are open wounds or lesions that usually develop on the sole of the foot and affect nearly 15% of individuals living with diabetes. They are commonly caused by a combination of nerve damage (neuropathy), reduced blood flow, and excessive pressure on certain areas of the foot, leading to skin deterioration that may rapidly progress to serious infection and, in severe untreated cases, amputation.
Dialysis is a vital treatment for individuals with kidney failure, designed to replicate the kidneys’ function by removing waste, toxins, and excess fluids from the bloodstream. It becomes essential when the kidneys are no longer able to regulate the body’s internal balance effectively. The two primary forms of dialysis are hemodialysis, which filters blood through an external machine, and peritoneal dialysis, which uses the lining of the abdomen to cleanse the blood within the body.
This study is designed to assess the efficacy and tolerability of GL0034 in individuals diagnosed with Type II Diabetes Mellitus who are either obese or overweight and present with weight-related comorbidities. The research seeks to examine how effectively GL0034 supports glycaemic control while also evaluating its safety profile and overall tolerability within this patient population. Additionally, the study aims to explore the potential impact of the treatment on weight management and associated health conditions commonly linked to obesity and excess body weight.
Available upon request
More than 10 years / Over 20 studies completed (Phases I-IV)
Multiple therapeutic areas
Phase I, II, III, IV
Access to the patient database from in-house and affiliated clinics
English, Spanish
Varies by protocol
- GCP Certified - IATA Certified - Experienced CRCs
3 investigators 2 ARPN 2 RN 5 CRCs 1 assistant 1 regulatory specialist 1 recruiter
Experienced with central IRBs.
Extensive
Yes (partially manual)
We operate multiple locations through out Florida, all of which are fully equipped and well-suited to support the successful conduct of clinical trials. Our headquarters is based at 10550 NW 77 Ct., Suite 401. Hialeah Gardens, FL 33016
